Cystic fibrosis breakthrough by RCSI team including MMI Clinician Scientist Fellow

Guest Lecture – TCD Department of Histopathology
May 28, 2012
Joint Irish Nutrigenomics Organisation (JINGO) Symposium 30th May
June 6, 2012
Show all

Cystic fibrosis breakthrough by RCSI team including MMI Clinician Scientist Fellow

Researchers from the Respiratory Research Division of the Department of Medicine, Royal College of Surgeons in Ireland (RCSI) have published a study which represents a major breakthrough in understanding why females with cystic fibrosis do worse than males.

Dr Sanjay Chotirmall, a Molecular Medicine Ireland (MMI) Clinician-Scientist fellow is the first author on the paper, published in New England Journal of Medicine*. Professor Gerry McElvaney, Director of the Respiratory Research Laboratory RCSI/Beaumont Hospital, Dr Catherine Greene and Professor Brian Harvey are the senior authors.

For more information, please see the news item on the RCSI website here

* Chotirmall, SH, Smith, SG, Gunaratnam, C, Cosgrove, S, Dimitrov, BD, O’Neill, SJ, Harvey, BJ, Greene, CM, McElvaney, NG. “Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis”. New England Journal of Medicine (10.1056/NEJMoa1106126)
About the Clinician Scientist Fellowship Programme (CSFP)

Since 2008, 22 medical graduates are undertaking PhD studies in five academic institutions as MMI Clinician Scientist Fellows. The CSFP is a structured PhD programme funded under PRTLI Cycle 4 which is training this key group of clinician scientists who will graduate with the unique and specialised knowledge essential to fulfil Ireland’s research needs in translational medicine.

Further information on the CSFP can be found at the below link:
https://www.crdi.ie/csfp